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ABSTRACT
The bacterial homologue of C4orf14, YqeH, has been
linked to assembly of the small ribosomal subunit.
Here, recombinant C4orf14 isolated from human
cells, co-purified with the small, 28S subunit of the
mitochondrial ribosome and the endogenous protein
co-fractionated with the 28S subunit in sucrose gra-
dients. Gene silencing of C4orf14 specifically affected
components of the small subunit, leading to decre-
ased protein synthesis in the organelle. The GTPase
of C4orf14 was critical to its interaction with the 28S
subunit, as was GTP. Therefore, we propose that
C4orf14, with bound GTP, binds to components of
the 28S subunit facilitating its assembly, and GTP
hydrolysis acts as the release mechanism. C4orf14
was also found to be associated with human mito-
chondrial nucleoids, and C4orf14 gene silencing
caused mitochondrial DNA depletion. In vitro
C4orf14 is capable of binding toDNA. The association
of C4orf14 with mitochondrial translation factors and
the mitochondrial nucleoid suggests that the 28S
subunit is assembled at the mitochondrial nucleoid,
enabling the direct transfer of messenger RNA from
the nucleoid to the ribosome in the organelle.
INTRODUCTION
The eukaryotic cell maintains small circles of DNA in
mitochondria in order to produce a handful of proteins.
Although few in number, the 13 proteins encoded in
human mitochondrial DNA (mtDNA) nevertheless make
critical contributions to aerobic adenosine triphosphate
(ATP) production. An accurate estimate of the number
of gene products that are required to maintain and
express mtDNA still eludes us, but it is expected to
exceed 200. Based on other systems (1), 200 proteins
could well be involved in mitochondrial translation, as
mitochondria harbour dedicated ribosomes (2).
Mitochondrial ribosomes are more closely related to
their prokaryotic antecedents, than their immediate
physical neighbours in the cytosol, as indicated by their
sensitivity to a range of antibiotics that target bacterial
ribosomes (3). In addition to ribosomal proteins,
mitochondria have inherited translation initiation, elong-
ation and termination factors from bacteria based on
sequence homology. Mitochondrial protein synthesis is
also of medical importance as defects in this process
account for an increasing number of cases of mitochon-
drial disease (4). Several studies have defined the compo-
nents of the mitochondrial ribosome and allied proteins
(5–7) yet our understanding of mitochondrial ribosomal
biogenesis is far from complete.
mtDNA is organized in nucleoprotein complexes, or
nucleoids. The identification of proteins in enriched prep-
arations of mtDNA from mammalian cells and tissues has
provided an extensive list of candidate nucleoid proteins
(8–11), although little is known of the functions of many
of them, at least in respect of mtDNA metabolism. Most
progress has been made in yeasts, where several seemingly
unlikely candidates, such as HSP60, a-ketoglutarate de-
hydrogenase and ilv5, an enzyme involved in amino acid
biosynthesis, have been shown to contribute to mtDNA
maintenance (12–15). Thus, mtDNA organization and
maintenance appear to be quite different to nuclear
DNA. mtDNA is also unlike nuclear DNA in that there
is no physical barrier to prevent concurrent transcription
and translation in mitochondria, and there is some
evidence that mitochondrial transcription and translation
are linked (16–18). If this is so, then one might expect
numerous translation factors to co-purify with mtDNA.
Here, we report that chromosome 4 open reading frame
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14, C4orf14 (or NOA1) is linked to mitochondrial
nucleoids and to the apparatus of mitochondrial transla-
tion, specifically the small mitochondrial ribosomal (28S)
subunit. It was identified in one preparation of TFAM
(mitochondrial transcription factor A) affinity-purified
nucleoids (19), and its prokaryotic homologue YqeH is a
guanosine triphosphate (GTP) binding protein of Era/Obg
family involved in the biogenesis of the bacterial small
ribosomal subunit (20–21). For this reason, and because
C4orf14 has also been implicated in DNA replication in
prokaryotes (23), we selected it for further study.
Recently, C4orf14 (NOA1) was reported to be required
for normal mitochondrial translation and respiratory
functions (24). It contains both a functional and highly
conserved circularly permuted GTPase domain (25), and
a predicted TRAP domain, suggesting that it could bind
to RNA (25,26). Here, we show that C4orf14 binds to the
small (28S) subunit of the mitochondrial ribosome and to
other mitochondrial translation factors, via a
GTP-dependent mechanism. C4orf14 is also a DNA-
binding protein, and so it potentially links the processes




Human osteosarcoma (HOS 143B cells) and human
embryonic kidney cells (HEK293T) were grown in
Dulbecco’s Modified Eagle’s Medium and 10% fetal
bovine serum. In the case of transgenic HEK293T cells,
the serum was tetracycline-free, and the medium included
15 mg/ml of blasticidin and 100 mg/ml of Zeocin or 100 mg/
ml of hygromycin and 15 mg/ml of blasticidin for control
and C4orf14 expressing cells, respectively.
Affinity purification of C4orf14 and TFAM from
HEK293T cells
Human complementary DNAs (cDNAs) of TFAM or
C4orf14, with a carboxy-terminal Strep II followed by a
FLAG tag, were introduced into HEK293T cells
(Invitrogen), to establish inducible, transgenic cell lines.
Transgene expression was induced with 2–20 ng/ml doxy-
cycline for 24–48 h. Mitochondria from HEK293T cells
were isolated by a method modified from (11), and the
tagged protein affinity purified as detailed in (19), except
that the second affinity purification step was not applied.
Mass spectrometry
Protein samples were fractionated by SDS–PAGE, stained
with Coomassie blue dye, excised and subjected to in-gel
tryptic digestion and then analysed in a MALDI-TOF-
TOF mass spectrometer (model 4800; ABI-Sciex) using
matrix a-cyano-4-hydroxycinnamic acid. Acquired peptide
mass data were compared with sequence databases using
MASCOT, and proteins were identified from a significant
peptidemass fingerprint (P< 0.05) or frompeptide fragmen-
tation data (P< 0.05). Most proteins were identified by
both criteria, see Supplementary Table S1. Stable isotope
labelling of proteins in cell culture (SILAC) experiments
were performed as for ATAD3B (ATPase family AAA
domain-containing protein 3) (19).
GDP treatment of strepactin columns with bound C4orf14
The strepactin column with bound recombinant C4orf14
from HEK293T-purified mitochondria was washed five
times with 20mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) pH 7.6, 5mM ethylenedia-
minetetraacetic acid, 150mM NaCl, 2mM dithitothreitol
(DTT), 0.2mM phenylmethanesulfonylfluoride (PMSF),
1v/50v Roche protease inhibitor solution, 0.05% n-
dodecyl-b-D-maltoside (wash buffer) and then incubated
with wash buffer supplemented with 20mM guanosine
diphosphate (GDP) pH 7.6, for 30min at 4C, and
washed a further five times with wash buffer containing
GDP. All five washes with GDP were pooled and dialysed
in 100 sample volume wash buffer overnight at 4C.
After dialysis, the ‘GDP-eluted’ material was incubated
with or without 20mM GTP and then re-loaded on two
new strepactin columns; thereafter the standard washes
and desthiobiotin elution procedure were applied.
Cell transfection
For RNAi experiments, 143B cells were transfected with
lipofectamine 2000 (Invitrogen) and 5 or 10nM
double-stranded (ds) RNA. After 48 or 72h, cells were
lysed and total RNA or DNA was extracted. The two
pairs of dsRNAs (Qiagen) targeting C4orf14 were 50-TTG
GGTTTCAGTAACACCTAA-30, and 50-TTGGGTGCTA
TAGGCCGCATA-30, respectively, known as C4orf14-3
and C4orf14-6. Qiagen: allstar neg. control siRNA, cat:
1027281 was used as a control dsRNA. PlasmidDNA trans-
fection was similar except that 1.5mg plasmidDNA replaced
dsRNA, and antibiotic selectionwas applied after 24 or 48h.
Estimation of transcript and mtDNA copy number
Mitochondrial mRNA abundance was estimated relative to
the mRNA for glyceraldehyde 3-phosphate dehydrogenase
(GAPDH).TotalRNAwas extracted fromcells withTRIzol
reagent (Invitrogen) and cDNA was generated with an
Omniscript reverse transcription kit with random hexamer
primers and oligo dT (Qiagen) according to the manufac-
turer’s instructions. mtDNA copy number and the relative
abundance ofmRNAwas estimated byquantitative PCR, as
described before (27). Primers with the following sequences
were employed: GAPDH, forward 50-GAAGGTGAAGGT
CGGAGTCAAC-30, reverse 50-CAGAGTTAAAAGCAG
CCC TGGT-30, probe 50-TTTGGTCCGTATTGGGCG
-30; APP, forward 50-TTTTTGTGTGCTCTCCCAGGTC
T-30, re-verse 50-TGGTCACTGGT TGGTTGGC-30, APP
probe 50-CCCTGAACTGCAGATCACCAATGCGGT
AG-30; COXII, forward 50-CGTCTGAACTATCCTGCC
CG-30, reverse 50-TGGTAAGGGAGGG ATCGTTG-30,
probe 50-CGCCCTCCCATCCCTACGCATC-30; Cyt b
forward 50-GCCTGCCTGATCCTCCAAAT-30, reverse 50-
AAGGTAGCGGATGATTCAGCC-30, probe 50-CACCA
GACGCCTCAACCGCCTT-30; C4orf14, forward 50-TCC
TGCAGGGAAATCAGTC-30, reverse primer 50-GTTCTT
TTCCACCCAT TGGA-30, probe 50-ATCAGAAGCATG
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CAGGTCATACGT-30. Probes contained a 50 Familial
Mediterranean fever fluorophore and a 30 TAMRA
quencher (Sigma Genosys). Cycle conditions were the
default setting on the ABI sequence detection system 7700.
DNA analysis
DNA extraction and Southern blotting were performed as
described previously (9). mtDNA copy number was
estimated by comparing the signal from a radiolabelled
probe to the major non-coding region, nucleotides
16343-151 of human mtDNA with that of a nuclear 18S
rRNA probe.
Immunoblotting
Immunodetection utilized antibodies to goat anti-human
POLG1 1 : 500 (Santa Cruz), rabbit anti-Cyt (cytochrome)
c 1 : 200 (Abcam), goat anti-VDAC (1 : 1000, Santa Cruz),
mouse anti-TUFM 1 : 1000 (Abnova), mouse monoclonal
anti-FLAG M2 1 : 1000 (Sigma), rat anti-HA peroxidase
1 : 1000 (Roche), rabbit anti-POLMRT 1 : 1000 (Abcam),
rabbit anti-TOM20 1 : 20 000 (Santa Cruz), rabbit
anti-MRPS29 and MRPL11 1 : 1000 (Cell Signaling), goat
anti-MRPS6, anti-MRPS10, anti-MRPL15 1 : 200 (Santa
Cruz), rabbit anti-Prohibitin 1 : 500 (BioLegend), rabbit
anti-DHX30 1 : 200 (Abcam), mouse anti-MRPS27 1 : 500
(Abcam), mouse anti-MRPS2 1 : 500 (Abcam), rabbit
anti-LRP130 1 : 500 (Santa Cruz technology), mouse
anti-SF2P321 1 : 1000 (BD Bioscience), rabbit anti-PTCD3
1 : 500 (Abcam), rabbit anti-HSPD11 : 5000 (Abcam), rabbit
anti-UQCRC (complex III): 1 : 3000 (Sigma), mouse
anti-SDH (SDHB, complex II), 1 : 500 (Mitoscience),
rabbit anti-cytochrome oxidase II 1 : 200 (Abcam), rabbit
anti-ERAL1 (E. coli Ras-like protein-Like 1) (1 : 2000)
(ProteinTech), C4orf14 1 : 500 (Abcam). Rabbit
anti-SSBP1 (1 : 500) and rabbit anti-TFAM (1 : 20 000)
were kind gifts of Drs M. Zeviani and R. Wiesner, respect-
ively. Rabbit anti-ATAD3 (1 : 50 000), anti-NIPSNAP1
(1 : 1000) anti-CRIF1 (1 : 2000), anti-ATPase b-subunit
1 : 2000, anti-POLG2 (1 : 200) and anti-NDUFS1
(1 : 10 000) were raised against recombinant proteins
produced in-house. Secondary antibodies were anti-rabbit
or anti-mouse HRP 1 : 1000 (Promega).
Mitochondrial translation
The translation of proteins encoded inmtDNAwas assayed
by 35S-methionine labelling for 30min, in the presence of
emetine, after which total cellular protein was fractionated
by SDS–PAGE, as described before (28). The proteins were
fixed for 30min in 7%acetic acid, 20%methanol, dried and
exposed to phosphorimager plates. Radiolabelled proteins





FLAG-tagged C4orf14 was detected in transgenic
HEK293T cells with IgG mouse monoclonal anti-FLAG
antibody M2 (1 : 1000, Sigma) and goat anti-mouse-
Alex-Fluro

488 (1 : 1000, Invitrogen); TFAM was detected
with rabbit polyclonal anti-TFAM antibody (1 : 400) and
goat anti-rabbit Alex-Fluro

647 (1 : 1000, Invitrogen).
Antibodies were diluted in phosphate buffered saline in
5% serum. Slides were mounted using ProLong Gold
antifade with DAPI (40,6-diamidino-2-phenylindole,
Invitrogen). Cells were imaged with a Zeiss LSM 510 Meta
confocal microscope used in conjunction with LSM 510
software. Images were acquired with a Zeiss 63/1.40 oil
immersion objective, set at zoom 2.4. MitoTracker orange
signal was pseudocoloured red to improve contrast. Images
were edited in Photoshop Elements (Adobe).
Isokinetic sucrose-gradient analysis
of mitochondrial ribosomes
Mitochondria were isolated from control HEK293T cells
and cells induced to express recombinant C4orf14 with
20ng/ml doxycycline for 24h. After, isolation of mitochon-
dria from the interface of a 1/1.5M sucrose-gradient, 10mg
of mitochondria were lysed with 1% n-dodecyl-b-D-
maltoside, 20mM HEPES–KOH pH 7.6, 100mM KCl,
1/25 v/v inhibitor, 0.4mM PMSF, 2mM DTT, 20mM
MgAc2, centrifuged at 1000gmax, 10min and the 0.5ml
supernatant was loaded onto a 10–30% (v/v) linear sucrose
gradient in buffer (20mM HEPES–KOH pH 7.6, 100mM
NaCl, 1/50 v/v inhibitor, 0.2mM PMSF, 2mM DTT,
20mMMgAc2) containing 0.05% n-dodecyl-b-D-maltoside
and 50mg/ml chloramphenicol, and centrifuged for 16h at
100 000gmax, 4
C. Fractions (0.5ml) were collected, and the
distribution of ribosomal subunits through the gradient was
assessed by the detection of MRPS29 and MRPL11 and
other proteins by immunoblotting.
Iodixanol gradient analysis of mitochondrial lysates
Iodixanol gradient fractionationwas as previously described
(10). Briefly, sucrose gradient purified HEK293T cell
mitochondria were lysed with 0.4% n-dodecyl-b-D-malto-
side, and a 1000gmax supernatant loaded on a 20–42.5%
iodixanol gradient and centrifuged at 100 000gmax for 14 h.
Fractions of 0.5ml were collected from the base of the tube,
and nucleic acids and proteins from the various fractions
were resolved by 1% agarose and 4–12% polyacrylamide
gel electrophoresis, respectively.
Protein expression and purification
The C4orf14 cDNA was purchased from Cambridge
Bioscience (clone # 3504209), and a DNA fragment
corresponding to residues 63–698 of the protein was
amplified and cloned into pMAL-c2 (NEB), and trans-
fected into shuffle T7 cells. Expression in exponentially
growing cells was induced with 200 mM isopropyl
1-thio-b-D-galactopyranoside. After 18 h at 30C, cells
were collected and stored at 80C. Amylose column
affinity purification was performed according to the
manufacturer’s instructions (NEB), and fractions of
interest were pooled, concentrated and applied to a size
exclusion chromatography column (Superose 6, GE
Health care) in 50mM Tris–HCl, pH 7.5, 200mM NaCl,
10% glycerol, and 5mM dithiothreitol, to purify further
the proteins. Protein concentrations were evaluated using
DC protein assay reagent (Bio-Rad). The protein’s identity
was confirmed by mass spectrometry (MS) analysis. Rat
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TFAM (NM_031326.1) was C-terminally FLAG tagged
and purified from Escherichia coli carrying the
pLysS-Rare plasmid (Novagen). The soluble fraction of
E. coli cell lysate was mixed with anti-FLAG M2 affinity
gel (Sigma, A2220) and the recombinant TFAM eluted by
competition with FLAG peptide (Sigma, F3290), accord-
ing to the manufacturer’s instructions.
DNA and RNA binding assays
For DNA–protein gel retardation analysis, reaction
mixtures of 10ml, containing 50mM Tris (pH 7.4), 0.2mg/
ml bovine serum albumin, 2mM dithiothreitol, 32P-dCTP
labelled DNA (170-bp of pUC19), and 1ml protein were
incubated at 37C for 20min. After the incubation, 2ml of
loading buffer (50% glycerol, 0.1% bromophenol, 0.1%
xylene-cyanol) was added and after a further 20min on
ice, 8ml of each sample was loaded onto a 1 tris-borate-
EDTA (TBE), 4% polyacrylamide gel (PAG). The gel was
electrophoresed at 100V for 2 h at 4C, dried and exposed to




RNA from purified mitochondria of HEK293T cells was
end-labelled with g32P-ATP and mixed with different
amounts of maltose-binding protein (MBP), or
C4orf14-MBP, in reaction volumes of 10ml, at 37C for
20min. The products of the reaction were separated on
1% TBE agarose gels by electrophoresis at 120V for 3 h at
4C.C4orf14-MBPbinding tomtRNAwas tested bymixing
60mg protein with 1.6mg mtRNA. After immobilizing
C4orf14-MBP on 100ml amylose beads (New England
Biolab) and washing five times with 1ml 150mM NaCl,
the captured RNA was released by boiling, end-labelled
and used to probe membranes containing the equal
amounts of amplified mtDNA. The PCR products were







30; 16S rRNA, forward 50-AAATAGTGGGAAGATTTA
TAGGTAG-30, reverse 50-AGGATTGCGCTGTTATC C
CTAG-30.
RESULTS
C4orf14 (NOA1) was identified in one preparation of
TFAM affinity-purified nucleoids by mass spectrometry,
together with many proteins involved in mitochondrial
translation (19). Its prokaryotic homologue, YqeH, has
been implicated in the biogenesis of the bacterial small ribo-
somal subunit, and in DNA replication (20,21,23), and so
we speculated that C4orf14 might play dual roles in protein
synthesis and DNA metabolism in mitochondria. First, we
confirmed that C4orf14 was enriched in preparations of
affinity-purified recombinant TFAM isolated from
human embryonic kidney (HEK293T) cells, via
immunodetection (Figure 1A). Moreover, mitochondrial
ribosomal proteins and ancillary factors were also
captured with recombinant TFAM, whereas highly
abundant components of respiratory chain complexes
were depleted almost to extinction during the purification
process (Figure 1A).
C4orf14 physically and functionally interacts with the
small mitochondrial ribosomal subunit
In order to investigate C4orf14 in further detail, a human
cDNA of C4orf14 with FLAG and StrepII tags was cloned
and expressed in HEK293T Flp-In T-Rex cells. Exclusive
targeting to mitochondria of C4orf14.FLAG.StrepII
protein was demonstrated by immunocytochemistry and
its distribution in mitochondria was found to be similar,
albeit not identical, to that of TFAM (Figure 1B). In an
effort to identify the binding partners of C4orf14, three
TAP experiments were performed using C4orf14 as the
bait, and the bound proteins were identified by
MALD-TOF-TOF MS. A substantial majority of the
proteins identified in each preparation were protein
components of the 28S mitochondrial ribosomal subunit
[Figure 2A and Supplementary Table S1 (2,29,30)]. In
marked contrast, MS identified no component of the
large 39S subunit. The absence of components of the 39S
subunit co-purifying with C4orf14 strongly suggests
C4orf14 interacts specifically with the small mitochondrial
ribosomal subunit (directly, or indirectly).
As a more sensitive and less error prone test of C4orf14’s
major protein partners, SILAC coupled to Orbitrap liquid
chromatography (LC)/MS/MSanalysis (31) was performed.
Heavy labelled proteins purified on a streptactin column
from mitochondria of HEK293T cells expressing
C4orf14.FLAG.StrepII tagged protein, were mixed with
an equal amount of material isolated by the same procedure
from control HEK293T cells grown in medium without
heavy isotopes. Affinity purified proteins were considered
to be associated with the bait protein when they were
present in a 2-fold, or greater, excess over corresponding
proteins in control mitochondria, in both of the experiments
performed. Forty-five proteins fulfilled these criteria, and
the list of candidate partners of C4orf14 was dominated by
proteins of the mitochondrial small ribosomal subunit
(Table 1). Several of the other proteins have also been
linked to mitochondrial protein synthesis, or mtRNA me-
tabolism (see ‘Discussion’ section).
Centrifugation on sucrose gradients is widely used to frac-
tionate mitochondrial and other ribosomal subunits.
Analysis of the distribution of C4orf14 on such gradients
indicated that the endogenous protein co-fractionates with
the components of the small mitochondrial ribosomal
subunit (Figure 2B); thereby corroborating the affinity
capture data for recombinant C4orf14 (Table 1 and
Supplementary Table S1 and Figure 2A). The recombinant
protein also resolved on sucrose gradients in the same region
as the 28S subunit (Supplementary Figure S1). Next, gene
silencing with either one of two dsRNAs (c3 and c6) target-
ingC4orf14was performed onhumanosteosarcoma cells, to
determine the effects onmitochondrial translation andmito-
chondrial ribosomes. Both dsRNAs greatly reduced the ex-
pression of C4orf14 (Supplementary Figure S2A), and this
was associated with a marked decrease in mitochondrial
protein synthesis [Figure 2C (i)], confirming an earlier
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report that demonstrated decreased mitochondrial transla-
tion in aC4orf14 (NOA1) knockoutmouse (24). In addition,
we found that RNAi of C4orf14 decreased the steady-state
levels of two components of the 28S subunit (MRPS2 and
MRPS29), but not the 39S subunit componentsMRPL3and
MRPL11 [Figure 2C (ii)], and one of the two dsRNAs (c3)
specifically decreased the expression of 12S rRNA
(Figure 2D and Supplementary Figure S2B). The other
dsRNA, c6, induced a decrease in the steady-state level of
all five mitochondrial transcripts tested (Figure 2D and
Supplementary Figure S2B), which may be well due to the
off-target effects of the dsRNA. Whatever the cause of the
broader effects of dsRNA c6 compared to c3, they did not
exacerbate the defect in protein synthesis or the decrease in
the levels of 28S subunit components that were equally
marked for the two dsRNAs (Figure 2C). Thus, several
lines of evidence suggest that C4orf14 physically and func-
tionally interacts with the mitochondrial small ribosomal
subunit (Table 1 and Supplementary Table S1, Figure
2A–D), rather than the 39S subunit as was previously
suggested (24). Moreover, our reassignment of C4orf14 as
a 28S subunit interacting protein is consistent with earlier
studies that linked C4orf14’s prokaryote homologue
(YqeH) to biogenesis of, the small ribosomal subunit (22).
C4orf14 interacts with the small mitochondrial ribosomal
subunit via a GTP-binding mechanism
Because C4orf14 has a predicted GTPase domain and
GTPases play multiple roles in ribosomal biogenesis in
other systems (1), GTP was deemed likely to play a
critical role in the interaction of C4orf14 with components
of the small mitochondrial ribosomal subunit. Therefore,
the purification procedure for taggedC4orf14 wasmodified
by addingGDP to the wash buffer, as a competitor of GTP.
This resulted in the release of a considerable amount of the
mitochondrial small ribosomal subunit from the streptactin
column (Figure 3A). It is inferred that an excess of GDP
leads to many copies of C4orf14 binding to the nucleotide
diphosphate in place of GTP, inducing a conformational
Figure 1. C4orf14 co-purifies with FLAG-StrepII-tagged TFAM and C4orf14.FLAG.StrepII is targeted to mitochondria in HEK293T cells. (A)
Affinity purified TFAM.FLAG.StrepII protein was isolated from mitochondria fractions of HEK293T cells. Proteins from various stages of the
purification procedure were analysed by immunoblotting, after separation via 4–12% SDS–PAGE. S, supernatant; F, flow-through; w, washes; e,
eluted fractions. PvuII digested mtDNA was detected by Southern hybridization. (B) Immunocytochemistry of C4orf14. FLAG.StrepII expressing
HEK293T cells with an anti-FLAG antibody (green) 24 h after transgene induction. Additionally, TFAM was labelled with an antibody (false-colour
violet), mitochondria were stained with MitoTracker (false-colour red) and the nucleus was stained with DAPI (blue). Bottom right: merged image of
C4orf14 and TFAM. The 4merged image (bottom left) is C4orf14, TFAM, DAPI and MitoTracker. White arrows in the enlarged images (bottom
centre) indicate foci where TFAM and C4orf14 coincide within the mitochondrial network. The ellipses each enclose two TFAM labeled foci, one of
which coincides with C4orf14.
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change, which results in the release of the 28S subunit. The
fact that GDP also released some tagged C4orf14 suggests
that multiple copies of the protein form a complex with the
28S subunit. The tagged protein together with components
of the 28S subunit and ERAL1 (a 28S subunit assembly
factor) (17,32) were re-captured on a fresh column when
the eluted material was first dialysed and then supple-
mented with GTP, whereas in the absence of GTP
tagged-C4orf14 was retained without 28S subunit compo-
nents, or ERAL1 (Figure 3A). These results indicate that
C4orf14’s interaction with the 28S subunit, and ancillary
factors, is reversible and dependent on GTP.
Three residues are predicted to be critical for C4orf14’s
GTPase activity (25), and their mutation abolishes the
GTPase activity of the plant homologue of C4orf14 (26).
The introduction of the mutations D251N, T384A and
D496V in the G4, G2 and G3 motifs, respectively (25),
led to the mutant form of C4orf14, known as m3, which
was no longer co-purified with the 28S subunit, or other
predicted or known mitochondrial translation factors
(Figure 3B and Supplementary Figure S3); nor did it
co-fractionate with the 28S subunit on sucrose gradients,
unlike the endogenous protein and recombinant GTPase
active C4orf14 (Supplementary Figure S4). Collectively,
these data suggest that C4orf14’s interaction with the
small mitochondrial ribosomal subunit (and/or its associ-
ates) is dependent on GTP, and that GTP hydrolysis is the
mechanism by which the 28S subunit is released by
C4orf14, presumably in a process that leads to assembly
of the monosome. Logically, GTP hydrolysis and 28S
subunit release by C4orf14 must precede assembly of the
55S monosome, as no 39S subunit co-purified with recom-
binant C4orf14, whereas purification of ATAD3 via the
same procedure yielded many components of both the 28S
and the 39S subunits, without C4orf14 (19). Thus, there is
nothing to suggest the purification procedure disrupts the
association between small and large subunits of the mito-
chondrial ribosome. The absence of any hint of 39S
subunit in our preparations of C4orf14 (MRPL12 aside,
see ‘Discussion’ section) strongly suggests the protein does
not participate in protein synthesis, but instead is involved
in 28S subunit maturation. It might additionally serve to
prevent premature translation initiation (1).
C4orf14 is associated with mtDNA and contributes to its
maintenance
YqeH, the bacterial homologue of C4orf14, has been
implicated inDNA replication (23), andC4orf14 co-purified
Figure 2. Association of C4orf14 with the mitochondrial small ribosomal subunit. (A) Affinity purified C4orf14.FLAG.StrepII protein was isolated
from mitochondria fractions of transgenic HEK293T cells and the concentrated eluted fractions resolved by SDS–PAGE. Proteins identified by MS
are indicated on the left and right of the gel. They included 22 polypeptides of the 28S subunit (MRPS; see Supplementary Table S1);
(B) sucrose-gradient purified mitochondria from HEK293T cells were lysed and fractionated on sucrose gradients. Antibodies to MRPS2 and
MRPS18, and MRPL3 and MRPL11 were used as markers of the 28S and 39S subunits, respectively. (C) 143B cells were transfected with
dsRNA (c3 or c6) targeting C4orf14 mRNA and the effects on mitochondrial protein synthesis (i); selected proteins in mitochondria (ii) and
mitochondrial ribosomal RNAs (panel D and Supplementary Figure S2) were examined 72 h later. GAPDH: glyceraldehyde-3-phosphate dehydro-
genase, the outer mitochondrial membrane protein TOM20, a putative mitochondrial RNA helicase DHX30 and components of the 55S ribosome
(MRPS2, MRPS29, MRPL3 and MRPL11).
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with recombinant tagged TFAM (Figure 1A). Therefore,
we analysed the effects of C4orf14 gene silencing on
picogreen staining of mtDNA and copy number. Treating
osteosarcoma cells for 72h with either one of two siRNAs
targeting C4orf14 (c3 or c6) halved mtDNA copy number,
based on Southern hybridization and qPCR (Figure 4A).
Both methods recorded a significant decrease in mtDNA
copy number as a result of C4orf14 gene silencing
Table 1. Protein interactions with C4orf14 identified by Orbitrap LC/MS/MS analysis and quantified by SILAC labelling
Protein names Gene name(s) Isotope ratios
Experiment 1 Experiment 2
Uncharacterized protein C4orf14 C4orf14 33.3 30.1
28S ribosomal protein S22, mitochondrial MRPS22 30.8 30.0
28S ribosomal protein S27, mitochondrial MRPS27 28.3 27.0
28S ribosomal protein S28, mitochondrial MRPS28; MRPS35 27.5 26.4
28S ribosomal protein S17, mitochondrial MRPS17 27.1 30.1
28S ribosomal protein S23, mitochondrial MRPS23 26.0 25.8
28S ribosomal protein S15, mitochondrial MRPS15 24.4 15.7
28S ribosomal protein S2, mitochondrial MRPS2 24.4 36.3
28S ribosomal protein S29, mitochondrial MRPS29 23.9 20.9
28S ribosomal protein S31, mitochondrial MRPS31 23.5 23.36
28S ribosomal protein S7, mitochondrial MRPS7 23.1 13.5
28S ribosomal protein S10, mitochondrial MRPS10 23.0 24.9
Pentatricopeptide repeat-containing protein 3,
mitochondrial
PTCD3 22.2 24.0
28S ribosomal protein S5, mitochondrial MRPS5 21.4 24.4
28S ribosomal protein S6, mitochondrial MRPS6 21.0 17.1
28S ribosomal protein S34, mitochondrial MRPS34 20.9 14.9
28S ribosomal protein S11, mitochondrial MRPS11 19.8 32.4
28S ribosomal protein S9, mitochondrial MRPS9 19.7 21.8
28S ribosomal protein S13, mitochondrial MRPS26 19.5 9.23
28S ribosomal protein S25, mitochondrial MRPS25 19.3 20.5
28S ribosomal protein S14, mitochondrial MRPS14 17.1 21.9
28S ribosomal protein S21, mitochondrial MRPS21 17.0 22.8
Malonyl-CoA-acyl carrier protein transacylase,
mitochondrial
MCAT 16.7 9.17
28S ribosomal protein S18-2, mitochondrial MRPS18B 16.2 9.63
Conserved ERA-like GTPase ERAL1 14.9 3.94
130 kDa leucine-rich protein;GP130; leucine-rich PPR
motif-containing protein, mitochondrial
LRP130;LRPPRC 13.8 5.18
28S ribosomal protein S24, mitochondrial MRPS24 12.6 17.2
Methyltransferase 11 domain-containing protein 1;





Complement component 1 Q subcomponent-binding
protein, mitochondrial
C1QBP 10.7 5.54
Pentatricopeptide repeat-containing protein 1 PTCD1 10.7 2.86
Probable serine carboxypeptidase CPVL CPVL;PSEC0124 10.3 9.08
RNA methyltransferase-like protein 1 RNMTL1 10.1 2.12
28S ribosomal protein S33, mitochondrial MRPS33 9.34 19.4
Mitochondrial ATP-dependent protease Lon LONP1 9.30 6.38
39S ribosomal protein L12, mitochondrial MRPL12 9.29 2.65
Mitochondrial 12S rRNA dimethylase 1 TFB1M 9.22 5.44
DNA-directed RNA polymerase, mitochondrial POLRMT 6.73 2.66
Mitochondrial transcription factor 1 TFAM 4.12 3.72
3-hydroxy-2-methylbutyryl-CoA dehydrogenase MRPP2;HADH2 2.76 2.79
Leucine-rich repeat-containing protein 59 LRRC59 2.70 5.18
Pyrroline-5-carboxylate reductase 2 PYCR2 2.65 2.74
Aldehyde dehydrogenase family 18 member A1 ALDH18A1 2.14 3.15
Caseinolytic peptidase B protein homologue CLPB 2.09 2.60
Dihydrolipoamide succinyltransferase component of
2-oxoglutarate dehydrogenase complex
DLST 2.02 4.82
C4orf14.FLAG.StrepII protein was induced with 2 ng/ml doxycyline for 24 h, and the protein affinity purified from isolated mitochondria, prior to
MS analysis. The bait protein (C4orf14) and putative partners returned a ratio of 2 : 1 over control proteins. The data are derived from the
MaxQuant outputs from duplicate affinity purifications performed with SILAC labels and features proteins with test (T) to reference (R) ratios of
>2.0, where the test was mitochondrial lysates of HEK cells expressing tagged C4orf14 and the reference was mitochondrial lysates of control HEK
cells without the transgene (see ‘Materials and methods’ section and main text for details). The proteins identified are listed in decreasing ratios over
proteins in control samples in the first experiment. The ratios have been corrected to three significant figures and the names (gene and protein) for
each entry have been simplified, many synonyms were excluded for clarity.
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(P< 0.05, P< 0.01, unpaired student’s t-test, respectively),
with a combined P< 0.001 for both dsRNAs.
RNA interference of C4orf14 also inhibited picogreen
staining of mtDNA (Figure 4B) that is attributable to per-
turbed mtDNA topology [Supplementary Figure S5 and
(9)]. In addition to the 28S subunit, affinity purification of
tagged C4orf14 yielded TFAM (Figure 2A and Table 1) and
some mtDNA (Figure 4C). Although some well-established
mtDNA-binding proteins were not identified by MS, they
did co-purify with tagged C4orf14, based on immunoblot-
ting (Figure 4C). In particular, mtDNA polymerase g was
considerably enriched in preparations of affinity purified
C4orf14, whereas highly abundant proteins of the outer
and inner mitochondrial membrane were markedly
depleted during the affinity purification process (Figure
4C). And, as detailed above, endogenous C4orf14 was
enrichedwhenTFAMwas the bait protein (Figure 1A), sug-
gesting it is bound, directly or indirectly, to manymitochon-
drial nucleoids. C4orf14’s GTPase activity is not required
for its interaction with mitochondrial nucleoids, as the m3
variant co-purified mitochondrial nucleoid proteins,
POLG1, TFAM and SSBP1 (Figure 3B), as well as
mtDNA itself (Supplementary Figure S6), nor is it linked
to nucleoids via the translation apparatus (Figure 3B).
To determine if C4orf14 binds to nucleic acids, a recom-
binant form of the protein was purified from E. coli (see
‘Materials and methods’ section). Incubation with DNA
produced a substantial electrophoretic mobility shift
(Figure 5A), indicating that C4orf14 is capable of inter-
acting directly with mtDNA in vitro. Nevertheless,
protein–protein interactions could also contribute to
C4orf14’s association with mitochondrial nucleoids.
However, this does not appear to be the case for
TFAM, as it inhibited, rather than enhanced, C4orf14’s
interaction with DNA, in vitro (Figure 5A–C). Recom-
binant C4orf14 also bound to RNA, in vitro, based on
electrophoretic mobility shift assays (Figure 5D). To
determine if C4orf14 had any preference for 12S rRNA
Figure 3. Dependence of the interaction of C4orf14 with the 28S ribosomal subunit on its GTPase being functional and GTP. (A) A strepactin
column with bound recombinant C4orf14 was washed first with 150mM NaCl (black bar), and then with buffer containing 20mM GDP pH 7.6
(grey bar) (see ‘Materials and methods’ section). Proteins from the different stages of the purification procedure were stained with Coomassie blue
after fractionation by SDS–PAGE (upper gel image). After dialysis, the ‘GDP-eluted’ material (Gde) was incubated with (+GTP) or without (GTP)
and then re-loaded on new strepactin columns; thereafter the standard washes and desthiobiotin elution procedure were applied, and proteins from
various steps of the procedure were analysed by immunoblotting to detect recombinant C4orf14 (anti-FLAG antibody), the 28S subunit (MRPS2
and MRSP29) and the 28S subunit assembly factor ERAL1. (B) The upper part of the panel shows a schematic representation of C4orf14 indicating
the positions of the three mutated residues in the m3 mutant version of the transgene. G1–G5 are sequence motifs that are characteristic of circularly
permuted GTPases. The lower portion of the panel comprises a series of immunoblots of eluted fraction 3 (see Figure 4C), indicating the relative
abundance of established and candidate nucleoid proteins isolated with the wild-type (WT) and m3 versions of C4orf14. Of the proteins tested, the
m3 version of C4orf14 co-purified exclusively with established mtDNA-binding proteins (class I); many of the other (class II) nucleoid proteins are
known to contribute to mitochondrial protein synthesis (see ‘Discussion’ section).
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the protein was also incubated with purified mtRNA, and
the captured RNA was used to probe fragments of
mtDNA; it labelled fragments of mtDNA corresponding
to the 12S and 16S genes to similar extents (Figure 5E),
suggesting that it is a non-specific RNA-binding protein,
and so its interaction with the 28S subunit most probably
depends additionally on protein–protein interactions.
DISCUSSION
Based on this study C4orf14 is involved in 28S subunit
biogenesis and mtDNA maintenance. Recombinant
and endogenous C4orf14 not only co-purified and
co-fractionated with the 28S ribosomal subunit, mtDNA
and mtDNA-binding proteins (Table 1 and Supple-
mentary Table S1, Figures 2–4), its absence was associated
with depletion of components of the 28S subunit
[Figure 2C (ii)], presumably due to an inability to
assemble the small ribosomal subunit, and with mtDNA
depletion (Figure 4A). It is possible that the interactions of
C4orf14 with the 28S subunit and mitochondrial nucleoids
are independent of one another; however, assembly of the
28S subunit (and subsequently the 55S ribosome) at the
mitochondrial nucleoid would offer a number of advan-
tages: it would provide a means of co-regulating mtDNA
copy number and mitochondrial translation (in order to
satisfy respiratory demand), and would enable direct
transfer of mitochondrial mRNAs from the nucleoid to
mitochondrial ribosomes. Direct transfer is implied by
the fact that all detectable mRNAs are to be found in
complexes with ribosomes or mtDNA (19). Once
mRNAs have transferred to the translation machinery it
could disengage from the nucleoid, although the accom-
panying study of ATAD3 and allied proteins suggests
ribosomes remain in close proximity to nucleoids after
their assembly. A more detailed assessment of the candi-
date partner proteins of C4orf14 follows, which supports
the view that the protein is involved in the assembly of the
Figure 4. C4orf14 gene silencing decreases mtDNA copy number and PicoGreen staining of mitochondrial nucleoids; and affinity purification of
tagged C4orf14 co-purifies mtDNA-binding proteins. (A) Combined Southern hybridization and qPCR estimates of mtDNA copy number, from
143B cells exposed for 72 h to dsRNAs c3 or c6, compared to mock transfected cells (n=6 independent experiments, three qPCR and three Southern
hybridizations). (B) mitochondrial nucleoids (and the nucleus) were stained with picogreen, and the mitochondrial network was stained with
MitoTracker orange (pseudo-coloured red for contrast) in mock-transfected 143B osteosarcoma cells, and cells transfected with dsRNAs targeting
C4orf14. Cell images were captured 72 h after transfection with a Zeiss LSM510 confocal microscope. (C) mtDNA and mitochondrial nucleoid
proteins co-purified with affinity captured C4orf14.FLAG.StrepII. (i) SDS–PAGE showing Coomassie stained proteins from various stages of the
affinity purification process: S, 1000gmax supernatant after mitochondrial lysis; F, flow-through; w, wash. (ii) Southern blotting of PvuII digested
DNA from various stages of the affinity purification process. (iii) Immunoblotting of specific mitochondrial proteins from various stages of the
affinity purification process. Some samples (gray-lined) were fractionated on a separate gel, simultaneously and under identical conditions.
NDUFA11, a subunit of respiratory complex I; UQCRC1, a subunit of respiratory complex III; COXII, a subunit of respiratory complex IV;
ATP5F1, a subunit of respiratory complex V; VDAC, voltage-dependent anion channel of the outer mitochondrial membrane; other proteins are
described in the text.
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28S subunit and cooperates with proteins at the interface
of transcription and translation.
The co-affinity purification of recombinant C4orf14 with
a set of proteins associated with one particular complex,
the 28S subunit, and others allied to mitochondrial protein
synthesis, suggests the interactions are highly specific and
therefore likely to be legitimate. In the first SILAC experi-
ment, proteins of the mitochondrial 28S subunit occupied
20 of the top 22 positions (Table 1), the other two were
PTCD3, which has previously been linked to MRPS
(29,30), and the bait protein. The second SILAC experi-
ment was much the same (Table 1). The ability of the
recombinant protein to re-capture the 28S subunit only if
supplied with GTP, and the absence of appreciable
amounts of 28S subunit co-purifying with the GTPase
disabled variant of C4orf14 provided further strong
evidence of a meaningful interaction between the
proteins. Nevertheless it was important to establish links
between the endogenous protein and the 28S subunit. Gene
silencing of C4orf14 indicated that the 28S subunit is
dependent on C4orf14, as it led to depletion of components
of the 28S, but not the 39S, subunit, and the endogenous
protein co-fractionated with the 28S subunit on sucrose
gradients. Thus, there can be little doubt that C4orf14
interacts specifically with the 28S subunit, directly or indir-
ectly. With that in mind the list of candidate partners of
C4orf14 warrants close inspection. ERAL1 is involved in
assembly of the small mitochondrial ribosomal subunit
(17,32), and it is a candidate partner of C4orf14 based on
the SILAC analysis (Table 1). Moreover, it was enriched in
TFAM affinity capture experiments along with C4orf14
(Figure 1A), and it was captured by GTPase active, but
not GTPase disabled, C4orf14 (Figure 3B). Finally,
ERAL1’s interaction with C4orf14 is dependent on GTP
and disturbed by GDP (Figure 3A). Therefore, the data are
consistent with C4orf14 and ERAL1 acting in concert, as
part of a complex, to engineer 28S subunit assembly.
Although no protein assigned to the 39S subunit was
identified by MALDI-TOF-TOF mass spectrometry
(Figure 2A and Supplementary Table S1), the more sensi-
tive Orbitrap analysis identified MRPL12 as a putative
partner of C4orf14. It is noteworthy that no other
MRPL was identified in either of the two long lists of
121 and 115 proteins (data not shown), and only traces
of MRPL components could be detected by immunoblot-
ting (Figure 4), and so MRPL12 is the only assigned
component of the 39S subunit that potentially interacts
with C4orf14. Independent of its place in the mitochondrial
ribosome, MRPL12 interacts with POLRMT (it also
co-purified with C4orf14, see Table 1), and so MRPL12
might couple transcription and translation (18).
Specifically, MRPL12 may be involved in the handover
of mRNA from the transcription machinery to the trans-
lation apparatus, which initially comprises the 28S subunit
and other components of the translation apparatus, but not
the 39S subunit. LRP130, another candidate partner of
C4orf14 (Table 1), interacts with both mitochondrial
RNA and DNA (33–35), and so it also might contribute
to the transfer of RNA from the nucleoid to the translation
apparatus. The function of TFB1M is to modify the
Figure 5. Recombinant C4orf14 binds to DNA and to RNA non-specifically. (A–D) Gel-retardation assays using 53 nM radiolabelled 170-bp DNA
incubated with different amounts of recombinant C4orf14 as indicated, without (A), or pre-mixed with 2.8 -mM TFAM (B) or 5.6 mM TFAM (C) for
20min at 37C. The boxed lanes each contained the same amount of C4orf14 (14 mM). (D) Radiolabelled mtRNA was incubated without protein or
with 3.5, 7, 14 or 28 mM C4orf14-MBP for 20min at 37C, prior to separation by 1D-AGE. (E) C4orf14-MBP captured mtRNA (see ‘Materials and
methods’ section) was end-labelled and incubated with a Southern blot of amplified fragments of mtDNA corresponding to 12S and 16S rRNAs,
cytochrome c oxidase subunit II (COX2) and NADH dehydrogenase subunit 1 (ND1). Ribosomal RNAs are of much greater abundance than
mRNAs, which accounts for the disparity in signal between the two types of gene.
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ribosomal RNA of the 28S subunit (12S rRNA), to make it
fit for assembly with its protein partners (36), which
suggests C4orf14 is involved in the earliest stages of 28S
subunit assembly. HADH2 or MRRP2 is a component of
the mitochondrial RNase P complex, which has the ability
to process the polycistronic mitochondrial transcripts (37),
and so this suggests a system in which RNA is processed
shortly after synthesis and transferred directly to the trans-
lation machinery.
The known functions of the other proteins on the list
offer few obvious clues as to potentially meaningful inter-
actions with C4orf14, although given the high purity of
the preparations they should be considered as serious
candidate partners. None more so than MCAT, the mito-
chondrial malonyl-CoA-acyl carrier protein transacylase,
which was the highest scoring protein, aside from the 28S
subunit (Table 1), and so it may well moonlight in mito-
chondrial translation.
C4orf14 recruits components of the mitochondrial
protein synthesis apparatus, in addition to the 28S
ribosome subunit
Several factors involved in mitochondrial translation
(PTCD3, MRPS2, MRPS27, MRPS29, ERAL1 and
TUFM) were found to co-purify with wild-type C4orf14,
but not the GTPase disabled (m3) variant (Figure 3B).
These data suggest that C4orf14 is required for the recruit-
ment of a variety of components of the mitochondrial
translation apparatus, and therefore any protein co-purify-
ing with wild-type C4orf14, and not with GTPase disabled
C4orf14, potentially has a role in mitochondrial transla-
tion. In our parallel study, we found ATAD3, prohibitin
and CRIF1 in enriched mtDNA preparations and showed
that they contribute to mitochondrial protein synthesis
(19). Affinity capture of ATAD3, prohibitin and CRIF1
was adversely affected by disabling the GTPase of
C4orf14, whereas mtDNA and some other nucleoid
proteins were affinity captured with both C4orf14 m3
and wild-type proteins (Figure 3B and Supplementary
Figure S3). Therefore, the different binding properties of
GTPase active and disabled C4orf14 suggest a new classi-
fication scheme for mitochondrial nucleoid interacting
proteins. Class I nucleoid proteins are those that associate
with mtDNA independent of the apparatus of mitochon-
drial protein synthesis; they include TFAM, SSBP1 and
POLG1. Class II nucleoid proteins contribute to mitochon-
drial protein synthesis and functional C4orf14 is proposed
as the means by which they are recruited to mitochondrial
nucleoids. Candidate class II mitochondrial nucleoid
proteins with established links to mitochondrial protein
synthesis are the 28S subunit (based on MRPS29, S27
and S2), ERAL1, PTCD3, TUFM and SF2P32
(Figure 3B). To these can be added, ATAD3, prohibitin
and CRIF1, as they fully satisfy the definition of class II
nucleoid proteins [Figure 3 and (19)]. Some ATAD3 might
instead be recruited to mtDNA directly, possibly via the
D-loop (9), in which case it would belong to both classes of
nucleoid proteins. NIPSNAP1 is present in enriched prep-
arations of mitochondrial nucleoproteins (9,10) and it
behaves like a class II nucleoid protein (Figure 3B) and
so it may well play a role in mitochondrial translation.
Further more detailed comparisons of proteins associated
with GTPase-active and GTPase-disabled C4orf14 can be
expected to reveal additional factors in mitochondria that
contribute to protein synthesis.
This study implicates C4orf14 in DNA metabolism and
protein synthesis in mitochondria. The accompanying
article suggests that the same is true for ATAD3, and
possibly prohibitin too. Thus, the two studies point to
a new category of proteins operating at the interface of
DNA maintenance and expression. Such proteins might
be pivotal to balancing mtDNA copy number and
expression, as it is well known that mtDNA numbers are
closely related to energy demand in cells and tissues. An
analogous coordination of DNA replication and protein
synthesis has been proposed for prokaryotes based on
gene organization (38), and so the mitochondrial version
may have been inherited from its prokaryote ancestor.
SUPPLEMENTARY DATA
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